1,2-dipalmitoylphosphatidylcholine has been researched along with ammonium sulfate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar, LK; Barenholz, Y; Cohen, R; Haran, G | 1 |
| Asai, T; Fukuta, T; Honda, M; Namba, M; Oku, N; Yamamoto, H; Yanagida, M; Yanagida, Y | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and ammonium sulfate
| Article | Year |
|---|---|
Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Ammonia; Ammonium Sulfate; Doxorubicin; Drug Stability; Electric Conductivity; Hydrogen-Ion Concentration; Liposomes; Quality Control; Technology, Pharmaceutical | 1993 |
Release rate is a key variable affecting the therapeutic effectiveness of liposomal fasudil for the treatment of cerebral ischemia/reperfusion injury.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1,2-Dipalmitoylphosphatidylcholine; Ammonium Sulfate; Animals; Brain; Citric Acid; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Liposomes; Male; Phosphatidylcholines; Quaternary Ammonium Compounds; Rats, Wistar; Reperfusion Injury; Treatment Outcome | 2020 |